These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 25675409)

  • 21. The use of renin-angiotensin-aldosterone system (RAAS) inhibitors is associated with a lower risk of mortality in hypertensive COVID-19 patients: A systematic review and meta-analysis.
    Wang Y; Chen B; Li Y; Zhang L; Wang Y; Yang S; Xiao X; Qin Q
    J Med Virol; 2021 Mar; 93(3):1370-1377. PubMed ID: 33095513
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antihypertensive agents for preventing diabetic kidney disease.
    Lv J; Perkovic V; Foote CV; Craig ME; Craig JC; Strippoli GF
    Cochrane Database Syst Rev; 2012 Dec; 12():CD004136. PubMed ID: 23235603
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiotensin II receptor blocker or angiotensin-converting enzyme inhibitor use and COVID-19-related outcomes among US Veterans.
    Derington CG; Cohen JB; Mohanty AF; Greene TH; Cook J; Ying J; Wei G; Herrick JS; Stevens VW; Jones BE; Wang L; Zheutlin AR; South AM; Hanff TC; Smith SM; Cooper-DeHoff RM; King JB; Alexander GC; Berlowitz DR; Ahmad FS; Penrod MJ; Hess R; Conroy MB; Fang JC; Rubin MA; Beddhu S; Cheung AK; Xian W; Weintraub WS; Bress AP
    PLoS One; 2021; 16(4):e0248080. PubMed ID: 33891615
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Renin-angiotensin-aldosterone system inhibitors and SARS-CoV-2 infection: an analysis from the veteran's affairs healthcare system.
    Sandhu AT; Kohsaka S; Lin S; Woo CY; Goldstein MK; Heidenreich PA
    Am Heart J; 2021 Oct; 240():46-57. PubMed ID: 34126079
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cross-sectional associations of albuminuria among Aboriginal and Torres Strait Islander adults: the eGFR Study.
    Hughes JT; Maple-Brown LJ; Thomas M; Lawton PD; Sinha A; Cass A; Barzi F; Jones G; Jerums G; MacIsaac RJ; O'Dea K; Hoy WE
    Nephrology (Carlton); 2018 Jan; 23(1):37-45. PubMed ID: 29250918
    [TBL] [Abstract][Full Text] [Related]  

  • 26. First line drug treatment for hypertension and reductions in blood pressure according to age and ethnicity: cohort study in UK primary care.
    Sinnott SJ; Douglas IJ; Smeeth L; Williamson E; Tomlinson LA
    BMJ; 2020 Nov; 371():m4080. PubMed ID: 33208355
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Hypertensive Patients with COVID-19 (COVIDECA Study).
    Mustafic H; Fayssoil A; Josseran L; Ouadahi M; Grimaldi-Bensouda L; Dubourg O; Annane D; Mansencal N
    Am J Cardiol; 2021 May; 147():58-60. PubMed ID: 33617818
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The association of COVID-19 occurrence and severity with the use of angiotensin converting enzyme inhibitors or angiotensin-II receptor blockers in patients with hypertension.
    Li M; Wang Y; Ndiwane N; Orner MB; Palacios N; Mittler B; Berlowitz D; Kazis LE; Xia W
    PLoS One; 2021; 16(3):e0248652. PubMed ID: 33735262
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of monotherapy of temocapril or candesartan with dose increments or combination therapy with both drugs on the suppression of diabetic nephropathy.
    Ogawa S; Takeuchi K; Mori T; Nako K; Tsubono Y; Ito S
    Hypertens Res; 2007 Apr; 30(4):325-34. PubMed ID: 17541211
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Observational Study of Brain Atrophy and Cognitive Decline Comparing a Sample of Community-Dwelling People Taking Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Over Time.
    Moran C; Xie K; Poh S; Chew S; Beare R; Wang W; Callisaya M; Srikanth V
    J Alzheimers Dis; 2019; 68(4):1479-1488. PubMed ID: 30909218
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endothelial nitric oxide synthase gene polymorphisms and renal responsiveness to RAS inhibition therapy in type 2 diabetic Asian Indians.
    Cheema BS; Kohli HS; Sharma R; Bhansali A; Khullar M
    Diabetes Res Clin Pract; 2013 Mar; 99(3):335-42. PubMed ID: 23260854
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incipient Albuminuria in Persons with Newly Diagnosed Type 2 Diabetes Mellitus: A 5-Year Retrospective Cohort Study.
    Tan S; Wong LY; Toh MPH
    Ann Acad Med Singap; 2018 Dec; 47(12):502-508. PubMed ID: 30636266
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of ACEI/ARB, inflammatory cytokines, and antiviral drugs with liver dysfunction in patients with hypertension and COVID-19.
    Xiang D; Ren X; Chen Q; Yu H; Li X; Liu D
    Clin Exp Hypertens; 2021 May; 43(4):305-310. PubMed ID: 33356606
    [No Abstract]   [Full Text] [Related]  

  • 34. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease.
    Sharma P; Blackburn RC; Parke CL; McCullough K; Marks A; Black C
    Cochrane Database Syst Rev; 2011 Oct; (10):CD007751. PubMed ID: 21975774
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Real-world use of ACEI/ARB in diabetic hypertensive patients before the initial diagnosis of obstructive coronary artery disease: patient characteristics and long-term follow-up outcome.
    Zhang Y; Ding X; Hua B; Liu Q; Chen H; Zhao XQ; Li W; Li H
    J Transl Med; 2020 Apr; 18(1):150. PubMed ID: 32238168
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum uric acid level is associated with metabolic syndrome and microalbuminuria in Korean patients with type 2 diabetes mellitus.
    Kim ES; Kwon HS; Ahn CW; Lim DJ; Shin JA; Lee SH; Cho JH; Yoon KH; Kang MI; Cha BY; Son HY
    J Diabetes Complications; 2011; 25(5):309-13. PubMed ID: 21130003
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in high-risk clinical and ethnic groups with diabetes.
    Rosen AB; Karter AJ; Liu JY; Selby JV; Schneider EC
    J Gen Intern Med; 2004 Jun; 19(6):669-75. PubMed ID: 15209606
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of angiotensin converting enzyme inhibitors and angiotensin receptor blockers associated with lower risk of COVID-19 in household contacts.
    Armstrong K; Soltoff A; Rieu-Werden M; Metlay J; Haas J
    PLoS One; 2021; 16(3):e0247548. PubMed ID: 33651840
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of hospitalisation on the use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in elderly hypertensive patients.
    Wawruch M; Slezakova V; Murin J; Luha J; Bozik M; Leitmann T; Kuzelova M; Shah R
    Aging Clin Exp Res; 2014 Jun; 26(3):307-14. PubMed ID: 24781831
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is Chronic Kidney Disease Progression Influenced by the Type of Renin-Angiotensin-System Blocker Used?
    Silvariño R; Rios P; Baldovinos G; Chichet MA; Perg N; Sola L; Saona G; De Souza N; Lamadrid V; Gadola L
    Nephron; 2019; 143(2):100-107. PubMed ID: 31203280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.